Arq. Bras. Oftalmol. 2024; 87 (5): 10.5935/0004-2749.2022-0215
Total: 2599
Noy Ashkenazy1,3; J. William Harbour1,2,3; Sander R. Dubovy1,4; Thomas A. Albini1; Jayanth Sridhar1; Nish Patel1,5; Eric D. Hansen6; Eduardo Uchiyama7; Patrick E. Rubsamen7; Zelia M. Correa1,3
DOI: 10.5935/0004-2749.2022-0215
1. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
2. University of Texas Southwestern Medical Center, Department of Ophthalmology, Dallas, Texas
3. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida
4. Florida Lions Ocular Pathology Laboratory, University of Miami Miller School of Medicine, Miami, Florida
5. Henry Ford Hospital, Department of Ophthalmology, Detroit, Michigan
6. John A. Moran Eye Institute, University of Utah, Salt Lake City, Utah
7. Retina Group of Florida, Fort Lauderdale, Florida
Zelia M. Correa
E-mail: [email protected]
Funding: This study received no specific financial support.
Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
